RT Journal Article
T1 Myofunctional Therapy App for Severe Apnea-Hypopnea Sleep Obstructive Syndrome: Pilot Randomized Controlled Trial.
A1 O'Connor-Reina, Carlos
A1 Ignacio Garcia, Jose Maria
A1 Rodriguez Ruiz, Elisa
A1 Morillo Dominguez, Maria Del Carmen
A1 Ignacio Barrios, Victoria
A1 Baptista Jardin, Peter
A1 Casado Morente, Juan Carlos
A1 Garcia Iriarte, Maria Teresa
A1 Plaza, Guillermo
K1 apnea
K1 app
K1 efficacy
K1 mHealth
K1 myofunctional therapy
K1 oropharyngeal exercises
K1 randomized trial
K1 sleep
K1 sleep apnea
K1 smartphone app
K1 therapy
AB Myofunctional therapy has demonstrated efficacy in treating sleep-disordered breathing. We assessed the clinical use of a new mobile health (mHealth) app that uses a smartphone to teach patients with severe obstructive sleep apnea-hypopnea syndrome (OSAHS) to perform oropharyngeal exercises. We conducted a pilot randomized trial to evaluate the effects of the app in patients with severe OSAHS. Forty patients with severe OSAHS (apnea-hypoxia index [AHI]>30) were enrolled prospectively and randomized into an intervention group that used the app for 90 sessions or a control group. Anthropometric measures, Epworth Sleepiness Scale (0-24), Pittsburgh Sleep Quality Index (0-21), Iowa Oral Performance Instrument (IOPI) scores, and oxygen desaturation index were measured before and after the intervention. After the intervention, 28 patients remained. No significant changes were observed in the control group; however, the intervention group showed significant improvements in most metrics. AHI decreased by 53.4% from 44.7 (range 33.8-55.6) to 20.88 (14.02-27.7) events/hour (P Orofacial exercises performed using an mHealth app reduced OSAHS severity and symptoms, and represent a promising treatment for OSAHS. Spanish Registry of Clinical Studies AWGAPN-2019-01, ClinicalTrials.gov NCT04438785; https://clinicaltrials.gov/ct2/show/NCT04438785.
YR 2020
FD 2020-11-09
LK http://hdl.handle.net/10668/16464
UL http://hdl.handle.net/10668/16464
LA en
DS RISalud
RD Apr 19, 2025